Filed before 2025Filed 12 February 2018
Evelo Biosciences, Inc. has sold $50M so far
Evelo Biosciences, Inc., a biotech company based in Cambridge, MA, has sold $50M so far in its equity round, according to a filing dated 12 February 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 February 2018
- First filed
- 18 January 2017
- Round
- Equity round (amended filing)
- Amount sold
- $50M
- Offering size
- $50M
- Investors so far
- 11
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 1,729 tracked raises with an amount filed in 2018, and than 79% of the 160 in biotech.
Evelo Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 23 Mar 2018 | Amended filing | $81.5M | Another raise |
| 20 Feb 2018 | New filing | $47.5M | Another raise |
| 12 Feb 2018 | Amended filing | $50M | This raise |
| 18 Jan 2017 | New filing | $30.5M | This raise |
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.